Angela Cavalieri | November 18, 2016
One in 77 women will develop ovarian cancer in her lifetime. Because ovarian cancer has no defined symptoms, most women will be diagnosed at a late stage of the disease where metastatic lesions are found dispersed throughout the abdomen. Ovarian cancer is currently the fifth most common cause of cancer-related deaths in women. With new technology being developed at the Harper Cancer Research Institute, the ovarian cancer surgery success rate may ultimately improve significantly.
Ovarian cancer distinctly spreads in the abdomen generating many sites of cancer along the peritoneum, the tissue lining the abdominal cavity. The most common treatment of ovarian cancer includes a debulking surgery, or the removal of cancerous lesions from the abdominal/peritoneal cavity. Currently, ovarian cancer surgeries are considered a ‘success’ with the removal of all tumors 1cm or larger. However, with research being developed at the Harper Cancer Research Institute, this goal could soon become the removal of tumors as small as 1mm.